MiMedx Group, IncNASDAQ: MDXG

MIMEDX to Participate in Upcoming Investor Conferences

· Issued by MiMedx Group, Inc via GlobeNewswire

Summary by 6ix AI

Senior management of MiMedx Group, Inc. (MIMEDX), which provides products for wound care, burn and surgical uses, will take part in the Canaccord MedTech, Diagnostics and Digital Health & Services Forum on November 11, 2026 and the Craig-Hallum 17th Annual Alpha Select Conference on November 17, 2026, both in New York, NY.

Key details

  • At the Canaccord forum on Wednesday, November 11, 2026, MIMEDX will hold one-on-one sessions and give a presentation at 9:00 am EST, which will be webcast.
  • At the Craig-Hallum conference on Tuesday, November 17, 2026, MIMEDX will hold one-on-one sessions only.
  • Investors who want to meet senior management at these events may contact their Canaccord or Craig-Hallum representative.

6ix AI wrote this summary from the release below and checked it against the release.

MARIETTA, Ga., Nov. 06, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that members of its senior management will participate in the following investor conferences:

Canaccord MedTech, Diagnostics and Digital Health & Services Forum | New York, NY
Wednesday, November 11, 2026
1:1 sessions + presentation (9:00 am EST): webcast

Craig-Hallum 17th Annual Alpha Select Conference | New York, NY
Tuesday, November 17, 2026
1:1 sessions

Investors interested in meeting with senior management at these events may contact their respective Canaccord or Craig-Hallum representative.

About MIMEDX
MIMEDX is a pioneer and leader focused on helping humans heal. With more than a decade and a half of helping clinicians manage chronic and other hard-to-heal wounds, MIMEDX provides a leading portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. The Company’s vision is to be the leading global provider of healing solutions through relentless innovation to restore quality of life. For additional information, please visit www.mimedx.com.

Contact:
Matt Notarianni
Investor Relations
470-304-7291
[email protected]

View original source (GlobeNewswire)MiMedx Group, Inc on 6ix

Story so far

Earlier from MiMedx

All MiMedx news releases